Detail of "6981-18-6"

Reference

In vitro efficacy of some sulfonamides and sulfonamide-potentiating compounds, and of their combinations

In vitro efficacy of some sulfonamides and sulfonamide-potentiating compounds, and of their combinations. Suveges, Tibor; Toth, Imre (Orsz. Allategeszsegugyi Intez., Budapest, Hung.). Magy. Allatorv. Lapja, 32(2), 127-9 (Hungarian) 1977. CODEN: MGALA5. DOCUMENT TYPE: Journal CA Section: 3 (Biochemical Interactions) When tested in vitro, trimethoprim [738-70-5], ormetoprim [6981-18-6] and diaveridine [5355-16-8] were more active by themselves than in combination with sulfadimethoxine [122-11-2] and sulfaquinoxaline [59-40-5], against Salmonella cholerae suis, Pasteurella multiseptica, and Escherichia coli (isolated from piglets). Sulfadimethoxine and sulfaquinoxaline by themselves showed low activity. None of the compds. and combinations was active against E. coli isolated from calves or against Pseudomonas.

Animal drugs, feeds, and related products; sulfadimethoxine, ormetroprim

Animal drugs, feeds, and related products; sulfadimethoxine, ormetroprim. (United States Food and Drug Administration, Rockville, MD 20857, USA). Fed. Regist., 49(228), 46371, (English) 26 Nov 1984. CODEN: FEREAC. ISSN: 0097-6326. DOCUMENT TYPE: Journal CA Section: 17 (Food and Feed Chemistry) Section cross-reference(s): 63 A feed premix contg. 113.5 g sulfadimethoxine [122-11-2] and 22.7 g ormetoprim [6981-18-6]/lb is approved under the Federal Food, Drug, and Cosmetic Act, for control of furunculosis caused by Aeromonas salmonicida in trout and salmon. The feeding level is 50 mg active ingredients/kg body wt. daily, and must be withdrawn 42 days before release for stocking or before slaughter. A tolerance of 0.1 ppm is established for residues of both sulfadimethoxine and ormetoprim in the uncooked edible tissues of the fish.